A Study of a Single Dose of ASP3291 in Subjects With Ulcerative Colitis
This study has been completed.
Sponsor:
Telsar Pharma Inc.
Information provided by (Responsible Party):
Telsar Pharma Inc.
ClinicalTrials.gov Identifier:
NCT01320332
First received: March 15, 2011
Last updated: July 23, 2012
Last verified: July 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | August 2011 |
| Primary Completion Date: | August 2011 (Final data collection date for primary outcome measure) |